• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1的聚合反应。

Polymerization of plasminogen activator inhibitor-1.

作者信息

Zhou A, Faint R, Charlton P, Dafforn T R, Carrell R W, Lomas D A

机构信息

Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 2XY, United Kingdom.

出版信息

J Biol Chem. 2001 Mar 23;276(12):9115-22. doi: 10.1074/jbc.M010631200. Epub 2000 Dec 1.

DOI:10.1074/jbc.M010631200
PMID:11102455
Abstract

The activity of the serine proteinase inhibitor (serpin) plasminogen activator inhibitor-1 (PAI-1) is controlled by the intramolecular incorporation of the reactive loop into beta-sheet A with the generation of an inactive latent species. Other members of the serpin superfamily can be pathologically inactivated by intermolecular linkage between the reactive loop of one molecule and beta-sheet A of a second to form chains of polymers associated with diverse diseases. It has long been believed that PAI-1 is unique among active serpins in that it does not form polymers. We show here that recombinant native and latent PAI-1 spontaneously form polymers in vitro at low pH although with distinctly different electrophoretic patterns of polymerization. The polymers of both the native and latent species differ from the typical loop-A-sheet polymers of other serpins in that they readily dissociate back to their original monomeric form. The findings with PAI-1 are compatible with different mechanisms of linkage, each involving beta-strand addition of the reactive loop to s7A in native PAI-1 and to s1C in latent PAI-1. Glycosylated native and latent PAI-1 can also form polymers under similar conditions, which may be of in vivo importance in the low pH environment of the platelet.

摘要

丝氨酸蛋白酶抑制剂(丝氨酸蛋白酶抑制剂)纤溶酶原激活物抑制剂-1(PAI-1)的活性受反应环分子内掺入β-折叠A的控制,从而产生无活性的潜伏形式。丝氨酸蛋白酶抑制剂超家族的其他成员可通过一个分子的反应环与第二个分子的β-折叠A之间的分子间连接而发生病理失活,形成与多种疾病相关的聚合物链。长期以来,人们一直认为PAI-1在活性丝氨酸蛋白酶抑制剂中是独特的,因为它不会形成聚合物。我们在此表明,重组天然型和潜伏型PAI-1在低pH值下体外自发形成聚合物,尽管聚合的电泳模式明显不同。天然型和潜伏型物种的聚合物与其他丝氨酸蛋白酶抑制剂的典型环-A-片层聚合物不同,因为它们很容易解离回其原始单体形式。PAI-1的研究结果与不同的连接机制相容,每种机制都涉及反应环在天然PAI-1中向s7A和潜伏PAI-1中向s1C的β链添加。糖基化的天然型和潜伏型PAI-1在类似条件下也可以形成聚合物,这在血小板的低pH环境中可能具有体内重要性。

相似文献

1
Polymerization of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1的聚合反应。
J Biol Chem. 2001 Mar 23;276(12):9115-22. doi: 10.1074/jbc.M010631200. Epub 2000 Dec 1.
2
Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands.由失活的两亲性有机化学配体诱导产生的纤溶酶原激活物抑制剂-1聚合物。
Biochem J. 2003 Jun 15;372(Pt 3):747-55. doi: 10.1042/BJ20021868.
3
VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.VLHL纤溶酶原激活物抑制剂可从潜伏形式自发重新激活为活性形式。
Int J Mol Med. 2009 Jan;23(1):57-63.
4
Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility.1型纤溶酶原激活物抑制剂——通过蛋白水解敏感性探究潜伏型、活性型、反应中心裂解型和与纤溶酶原激活物复合型之间的构象差异。
Eur J Biochem. 1997 Sep 15;248(3):775-85. doi: 10.1111/j.1432-1033.1997.t01-1-00775.x.
5
The acid stabilization of plasminogen activator inhibitor-1 depends on protonation of a single group that affects loop insertion into beta-sheet A.
J Biol Chem. 1995 Nov 17;270(46):27942-7. doi: 10.1074/jbc.270.46.27942.
6
Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.纤溶酶原激活物抑制剂1。天然丝氨酸蛋白酶抑制剂的结构,与其他构象的比较及其对丝氨酸蛋白酶抑制剂失活的影响。
J Mol Biol. 2000 Mar 31;297(3):683-95. doi: 10.1006/jmbi.2000.3604.
7
Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.反应中心环和β链5A的构象变化伴随纤溶酶原激活物抑制剂1的温度依赖性抑制剂-底物转变。
Eur J Biochem. 1996 Oct 1;241(1):38-46. doi: 10.1111/j.1432-1033.1996.0038t.x.
8
Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.纤溶酶原激活物抑制剂-1处于活性构象并在结合配体时聚合,从而中和其活性。
Int J Mol Med. 2006 Mar;17(3):437-47.
9
Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂-1与组织纤溶酶原激活物及胰蛋白酶反应中米氏复合物的解离、酰化及构象变化步骤
Biochemistry. 2001 Oct 2;40(39):11742-56. doi: 10.1021/bi0107290.
10
Specific interactions of serpins in their native forms attenuate their conformational transitions.丝氨酸蛋白酶抑制剂(serpins)天然形式下的特异性相互作用会减弱其构象转变。
Protein Sci. 2007 Aug;16(8):1659-66. doi: 10.1110/ps.072838107. Epub 2007 Jun 28.

引用本文的文献

1
The structural basis for Z α-antitrypsin polymerization in the liver.肝脏中Zα-抗胰蛋白酶聚合的结构基础。
Sci Adv. 2020 Oct 21;6(43). doi: 10.1126/sciadv.abc1370. Print 2020 Oct.
2
Reactive centre loop dynamics and serpin specificity.反应中心环动力学与丝氨酸蛋白酶抑制剂特异性。
Sci Rep. 2019 Mar 7;9(1):3870. doi: 10.1038/s41598-019-40432-w.
3
Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1.番荔枝乙酰精宁annonacinone的特性研究,一种纤溶酶原激活物抑制剂-1的天然产物抑制剂
Sci Rep. 2016 Nov 23;6:36462. doi: 10.1038/srep36462.
4
The shapes of Z-α1-antitrypsin polymers in solution support the C-terminal domain-swap mechanism of polymerization.溶液中Z-α1-抗胰蛋白酶聚合物的形状支持聚合反应的C端结构域交换机制。
Biophys J. 2014 Oct 21;107(8):1905-1912. doi: 10.1016/j.bpj.2014.08.030.
5
A serpin released by an entomopathogen impairs clot formation in insect defense system.一种由昆虫病原体释放的丝氨酸蛋白酶抑制剂会损害昆虫防御系统中的血栓形成。
PLoS One. 2013 Jul 16;8(7):e69161. doi: 10.1371/journal.pone.0069161. Print 2013.
6
The roles of helix I and strand 5A in the folding, function and misfolding of α1-antitrypsin.螺旋 I 和 5A 链在 α1-抗胰蛋白酶折叠、功能和错误折叠中的作用。
PLoS One. 2013;8(1):e54766. doi: 10.1371/journal.pone.0054766. Epub 2013 Jan 29.
7
Mutagenesis of the bovSERPINA3-3 demonstrates the requirement of aspartate-371 for intermolecular interaction and formation of dimers.牛丝氨酸蛋白酶抑制剂 A3-3 突变体的研究表明天冬氨酸 371 对于分子间相互作用和二聚体形成是必需的。
Protein Sci. 2012 Jul;21(7):977-86. doi: 10.1002/pro.2078. Epub 2012 May 18.
8
Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1.尿激酶型纤溶酶原激活物与其抑制剂-1 识别的结构基础。
J Biol Chem. 2011 Mar 4;286(9):7027-32. doi: 10.1074/jbc.M110.204537. Epub 2011 Jan 3.
9
pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.组氨酸 119 和 138 介导神经丝氨酸蛋白酶抑制剂的 pH 依赖性稳定性;对β-折叠 A 和聚合的控制的影响。
Protein Sci. 2010 Feb;19(2):220-8. doi: 10.1002/pro.299.
10
pH induces thermal unfolding of UTI: an implication of reversible and irreversible mechanism based on the analysis of thermal stability, thermodynamic, conformational characterization.pH诱导尿胰蛋白酶抑制剂的热解折叠:基于热稳定性、热力学和构象特征分析的可逆和不可逆机制研究
J Fluoresc. 2008 Mar;18(2):305-17. doi: 10.1007/s10895-007-0270-5. Epub 2007 Nov 9.